中国医学创新2016，Vol.13Issue(31)：1-5,6,6.DOI:10.3969/j.issn.1674-4985.2016.31.001
肝脏血流分级阻断的临床应用（附375例报道）
The Clinical Use of Graded Hepatic Vascular Exclusion (A Report of 375 Cases)
摘要
Abstract
Objective:To conclude the application of graded hepatic vascular exclusion in liver transection.Method:375 cases who underwent liver resections from January 2011 to January 2016 were analysed retrospectively.The changes of hemorrhage after the first,second and third stages of blocking and the postoperative recovery were observed.Result:375 patients after the first grade hepatic portal block of 36.3%(136/375) obtained better surgical field,and no obvious hepatic vein bleeding.The remaining 239 patients underwent hepatic vein occlusion in inferior vena cava (the second grade block) of 59.5%(223/375) got good surgical field,liver section of hepatic vein bleeding was alleviated,4.3%(16/375) had no obvious change on the degree of liver section hemorrhage,16 cases of hemorrhage patients underwent hepatic inferior vena cava occlusion (the third grade block),5 cases of bleeding severity.The first and second grades of the operation time, blood flow blocking effect of blocking time and blood loss during operation on liver function had no significant difference(P>0.05). Compared with the first and second grades block,the third grade block had longer operation time,longer blood occlusion time,more bleeding and greater influence on liver function,there were statistically significant differences(P<0.05). There were no significant differences in the length of hospital stay and renal function in the three blocking methods(P>0.05),all patients had no severe complications and death.Conclusion:Graded hepatic vascular exclusion can be performed according to the different bleeding degree of the cut surface of the liver. It can safe,convenient and effective to control the bleeding from the cut surface during liver transection.It makes clear and precise liver resection come true.关键词
肝脏血流阻断/肝下/肝上/下腔静脉Key words
Hepatic vascular exclusion/Infrahepatic/Suprahepatic/Vena cava引用本文复制引用
魏小勇,周存才,涂强,游骁翔..肝脏血流分级阻断的临床应用（附375例报道）[J].中国医学创新,2016,13(31):1-5,6,6.基金项目
江西省优势科技创新项目（20152BCB24010）；江西省卫计委科技计划项目 （）
